See May's 10 most read stories, including COVID-19's clinical trials research and what firms have done to cope with disruptions caused by the pandemic.
Plant extract companies in China are seeing more demand for immune-related raw materials, but most are adopting a cautious stance when it comes to capacity building due to trade uncertainties brought on by COVID-19.
A two-week clinical trial led by renowned Chinese virologist Zhong Nanshan has shown that consuming the botanical TCM product Lianhua Qingwen (LH) capsules and undergoing the standard therapy can speed up recovery in COVID-19 patients.
This round-up looks at the latest China infant nutrition brand scandal, how probiotics can improve asthma control, and market developments from big brands, including BY-HEALTH and Nestle.
VitaHealth is tapping into growing demand among Singapore’s myopic population to push sales of its eye health supplements, with screen use increasing as more people work from home and join virtual meetings due to the COVID-19 pandemic.
The standard of nutritional clinical research in APAC has improved by “leaps and bounds” in recent years, but researchers still need to take note of pitfalls such as biased judgements because strong science provides the cornerstone of commercially successful...
Ayurvedic supplement and FMCG giant Dabur India is conducting a three-month clinical trial to test if its chyawanprash formula could help prevent healthy individuals from contracting COVID-19.
Yakult has opened three new China sales offices, with the Japanese firm hopeful it will lead to an additional 100,000 bottle sales per day in a key market.
The first webinar in NutraIngredients' groundbreaking online immunity series takes place on Tuesday (May 26) when we will be shining the spotlight on 'Clinical Research and Immunity in APAC'.
Some of the latest consumers trends can be seen from the growing understanding of vitamins for preventive health in Indonesia, and the rising popularity of probiotics, infant nutrition, and Foods for Special Medical Purposes (FSMPs) in China as more spend...
The top three purchase criteria for dietary supplements among Chinese consumers RE product quality (79%), ingredient list (60%) and quality assurance seal (53%), according to data from the United States Pharmacopeia (USP).
Australia’s Renovatio Bioscience has developed a new product that claims to strengthen the immune system using a combination of activated phenolics, quercetin, and sunflower extract.
An Indian research institute has developed a range of high protein and fibre foods, including cookies, bread, and rusks specially for COVID-19 patients.
The first webinar in NutraIngredients' groundbreaking online immunity series is now just a week away - but there is still plenty of time to register for free!
Foods for Special Medical Purposes (FSMPs), probiotics and infant nutrition are among the fast-rising categories in China’s e-commerce space, according to two sector specialists featured in our latest Nutrition Asia video series.
